Long Term Study of Canakinumab (ACZ885) in Patients With Gout

Novartis Investigative site, Capital Federal Buenos Aires

Novartis Investigative site, Jette

Novartis Investigative site, Kistarcsa

Novartis Investigative site, Eger

Novartis Investigative site, Debrecen

Novartis Investigative site, Zalaegerszeg

Novartis Investigative site, Taipei

Novartis Investigative site, Prague

Novartis Investigative site, Gaziantep

Novartis Investigative site, Madrid

Novartis Investigative site, Izmir

Novartis Investigative site, Taichung

Novartis Investigative site, Manisa

Novartis Investigative site, Kaohsiung City

Novartis Investigative site, Kaohsiung City

Novartis Investigative site, Seattle

Novartis Investigative site, Moscow

Novartis Investigative site, Moscow

Novartis Investigative site, Yaroslavl

Novartis Investigative site, Singapore

Novartis Investigative site, Saint Petersburg

Novartis Investigative site, Saint Petersburg

Novartis Investigative site, Chelyabinsk

Novartis Investigative site, Barranquilla

Novartis Investigative site, Bogotá

Novartis Investigative site, Bucaramanga

Novartis Investigative site, Floridablanca

Novartis Investigative site, Petrozavodsk

Novartis Investigative site, Sachsen

Novartis Investigative site, Bayern

Novartis Investigative site, Dessau

Novartis Investigative site, Guatemala City

Novartis Investigative site, Poznan

Novartis Investigative site, Wroclaw

Novartis Investigative site, Lisbon

Novartis Investigative site, Bratislava

Novartis Investigative site, Košice

Novartis Investigative site, Nitra

Novartis Investigative site, Piešťany

Novartis Investigative site, Trenčín

Novartis Investigative site, Pretoria

Novartis Investigative site, Ankara

Novartis Investigative site, Adana

Novartis Investigative site, Aydin

Novartis Investigative site, Jarrow